Q32 Bio is based in Cambridge. It has raised $60M in total funding. Latest round: Series B.
Q32 Bio funding overview
Q32 Bio is based in Cambridge. Q32 Bio has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2020. The round record for Q32 Bio runs through 2020; nothing later has been disclosed. Investors on record include OrbiMed Advisors, Acorn Bioventures, Osage University Partners, Atlas Venture, Abingworth, Sanofi Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
Q32 Bio at a glance
Total raised
$60M
Latest round
Series B
Latest round date
October 2020
Headquarters
Cambridge
Notable investors
OrbiMed Advisors, Acorn Bioventures, Osage University Partners, Atlas Venture, Abingworth, Sanofi Ventures, CU Healthcare Innovation Fund, Children’s Hospital Colorado Center for Innovation
Frequently asked about Q32 Bio funding
How much has Q32 Bio raised?
Q32 Bio has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Q32 Bio?
OrbiMed Advisors, Acorn Bioventures, Osage University Partners, Atlas Venture, Abingworth, Sanofi Ventures are named among the investors backing Q32 Bio.
What was the latest Q32 Bio funding round?
The most recent disclosed round is a Series B, announced in October 2020.
Where is Q32 Bio based?
Q32 Bio is based in Cambridge.
When did Q32 Bio last raise?
The last disclosed Q32 Bio round closed in October 2020 at Series B.
Every Q32 Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
